EKSO
Ekso Bionics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 1
Stock Price Surged Significantly
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
EPS Beats Expectation
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About EKSO
Ekso Bionics Holdings, Inc.
An industry leader in exoskeleton technology for medical and industrial use
Healthcare Equipment and Supplies
01/30/2012
08/09/2016
NASDAQ Stock Exchange
61
12-31
Common stock
101 Glacier Point, Suite A, San Rafael, California 94901
--
Ekso Bionics Holdings, Inc., was incorporated in Nevada on January 30, 2012 as PN Med Group Inc. The company designs, develops and markets exoskeleton products that enhance human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and is available to able-bodied and physically disabled people. The company has launched the following devices: (i) enabling people with neurological diseases that affect gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to recover and, in some cases, walk again; (ii) providing walking assistance to people with specific SCI levels in home and community settings; (iii) helping people with multiple upper limb injuries; and (iv) allowing industrial workers to engage in highly difficult and repetitive work for long periods of time.
Earnings Call
Q1/2025
Estimate EPS--
Actual EPS-0.12
Estimate Revenue4.62M
Actual Revenue3.38M
Ekso Bionics Q1 2025: Analyzing Contradictions in Distribution, Medicare Claims, and Reimbursement Clarity
May 07,2025 02:41
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS--
Actual EPS-1.24
Estimate Revenue4.31M
Actual Revenue2.06M
Ekso Bionics' Q2 2025: Key Contradictions in Revenue Growth and Market Expectations for Personal Health Products
Jul 28,2025 06:30
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
EKSO has released its 2025 Q3 earnings. EPS was reported at -0.54, versus the expected -0.96, beating expectations. The chart below visualizes how EKSO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
EKSO has released its 2025 Q3 earnings report, with revenue of 4.23M, reflecting a YoY change of 2.37%, and net profit of -1.42M, showing a YoY change of 31.42%. The Sankey diagram below clearly presents EKSO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
